Sort
34,240 grants matching “atherosclerosis”
Defining SMC phenotypes critical in late stage atherosclerosis pathogenesis
$740,894Gary K Owens · University Of Virginia · R01 · FY2020 · HL
Defining SMC phenotypes critical in late stage atherosclerosis pathogenesis
$740,894Gary K Owens · University Of Virginia · R01 · FY2021 · HL
Defining SMC phenotypes critical in late stage atherosclerosis pathogenesis
$740,894Gary K Owens · University Of Virginia · R01 · FY2019 · HL
Long-Term Observational Extension of Participants in the CREST-2 Randomized Clinical Trial
$740,873James F Meschia · Mayo Clinic Jacksonville · U01 · FY2025 · NS
The Microcirculation in Claudication and Exercise Rehabilitation
$740,776Emile R. Mohler · University Of Pennsylvania · R01 · FY2013 · HL
Probing The Dark Matter of the Genome in the NHLBI Family Heart Study
$740,725Michael A Province · Washington University · R01 · FY2015 · HL
Unexpectedly Profound Role of Water in Biology and Medicine
$740,698Gerald H Pollack · University Of Washington · R01 · FY2009 · GM
Lifecourse CVD Risk and Midlife Cognitive Trajectories and Brain Aging: Implications for Alzheimer's and Dementia Prevention
$740,671Kristine Yaffe · Northern California Institute/Res/Edu · R01 · FY2021 · AG
Impact of Clonal Hematopoiesis on the Progression of Kidney Disease
$740,540Cassianne Robinson-Cohen · Vanderbilt University Medical Center · R01 · FY2022 · DK
Exposure to Metal-Mixtures and Coronary Heart Disease Across Diverse Populations
$740,365Yu Chen · New York University School Of Medicine · R01 · FY2024 · ES
The role of protease activated receptor 2 in the initiation and progression of abdominal aortic aneurysm
$740,338Albert Phillip Owens III · University Of Cincinnati · R01 · FY2025 · HL
Sub Clinical Cardiovascular Disease in Youth (SEARCH CVD)
$740,338Dana Dabelea · University Of Colorado Denver · R01 · FY2010 · DK
Clinical translation of targeted intracoronary imaging for inflammatory activity
$740,316Guillermo J. Tearney · Massachusetts General Hospital · R01 · FY2025 · HL
Determinants of arterial function in hypertension
$740,241Iftikhar J Kullo · Mayo Clinic Rochester · R01 · FY2009 · HL
Controlling allbB3 function by altering its energy landscape
$740,041Joel S. Bennett · University Of Pennsylvania · P01 · FY2016 · HL
Nef in impaired efferocytosis: a novel mechanism for vascular disease in HIV
$739,827Masanori Aikawa · Brigham And Women'S Hospital · R01 · FY2025 · HL
Impaired Vasoreactivity, Sleep Degradation, and Impaired Clearance in the APOE4 Brain
$739,802Elizabeth A Proctor · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2025 · AG
Defining SMC phenotypes critical in late stage atherosclerosis pathogenesis
$739,747Gary K Owens · University Of Virginia · R01 · FY2018 · HL
Kids: Nocturnal Investigation into Glomerular Disease, Hypertension, and Transcriptomics (kNIGHT)
$739,712Christine B Sethna · Feinstein Institute For Medical Research · R01 · FY2025 · HL
Atheroprotective Gene Therapy
$739,701David A Dichek · University Of Washington · R01 · FY2019 · HL
Mental Stress and Myocardial Ischemia after MI: Sex Differences and Mechanisms
$739,642Viola Vaccarino Vaccarino · Emory University · R01 · FY2012 · HL
Epigenetic regulation of donor heart preservation mediated by Brd4
$739,562Ieng Lam Lei · Mayo Clinic Rochester · R01 · FY2025 · HL
Methyl Mercury Effect on Adolescent Development Renewal
$739,484Philip W Davidson · University Of Rochester · R01 · FY2014 · ES
Determinants of arterial function in hypertension
$739,416Iftikhar J Kullo · Mayo Clinic Rochester · R01 · FY2010 · HL
PAR 13-233 cART accelerates vascular aging in HIV infected subjects
$739,353Giovanni Schifitto · University Of Rochester · R01 · FY2015 · HL